Delcath Systems (DCTH) Competitors

CONMED (NYSE:CNMD) and Delcath Systems (NASDAQ:DCTH) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, community ranking, analyst recommendations, valuation and institutional ownership.

Do analysts rate CNMD or DCTH?

CONMED presently has a consensus price target of $73.20, suggesting a potential upside of 49.66%. Delcath Systems has a consensus price target of $22.75, suggesting a potential upside of 88.95%. Given Delcath Systems' stronger consensus rating and higher possible upside, analysts clearly believe Delcath Systems is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40
Delcath Systems	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has higher valuation and earnings, CNMD or DCTH?

CONMED has higher revenue and earnings than Delcath Systems. Delcath Systems is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CONMED	$1.31B	1.16	$132.42M	$4.24	11.54
Delcath Systems	$37.21M	10.82	-$47.68M	-$0.98	-12.29

Does the media prefer CNMD or DCTH?

In the previous week, CONMED had 5 more articles in the media than Delcath Systems. MarketBeat recorded 14 mentions for CONMED and 9 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 1.13 beat CONMED's score of 0.33 indicating that Delcath Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CONMED	2 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Delcath Systems	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community believe in CNMD or DCTH?

CONMED received 3 more outperform votes than Delcath Systems when rated by MarketBeat users. Likewise, 46.75% of users gave CONMED an outperform vote while only 27.50% of users gave Delcath Systems an outperform vote.

Company	Underperform	Outperform
CONMED	Outperform Votes 36 46.75%	Underperform Votes 41 53.25%
Delcath Systems	Outperform Votes 33 27.50%	Underperform Votes 87 72.50%

Do insiders & institutionals believe in CNMD or DCTH?

61.1% of Delcath Systems shares are owned by institutional investors. 3.1% of CONMED shares are owned by insiders. Comparatively, 17.9% of Delcath Systems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Which has more volatility and risk, CNMD or DCTH?

CONMED has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500. Comparatively, Delcath Systems has a beta of 0.85, indicating that its share price is 15% less volatile than the S&P 500.

Is CNMD or DCTH more profitable?

CONMED has a net margin of 10.13% compared to Delcath Systems' net margin of -150.70%. CONMED's return on equity of 14.31% beat Delcath Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CONMED	10.13%	14.31%	5.64%
Delcath Systems	-150.70%	-338.16%	-104.02%

Summary

CONMED beats Delcath Systems on 11 of the 18 factors compared between the two stocks.